July 2026

Sovereign Metals has unveiled a robust Definitive Feasibility Study for its Kasiya project, projecting a US$2.2 billion pre-tax NPV and positioning the mine as a critical non-Chinese supplier of rutile, graphite, and heavy rare earths to the US and allies.

Black Rock Mining has secured an extension to its US$204 million credit facility to November 2026, providing crucial runway to finalise equity funding for its Mahenge Graphite Project. Early works are nearing completion, positioning the project for construction pending full funding and Final Investment Decision.

Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.

Comet Ridge has completed a $40.9 million capital raise combining a Share Purchase Plan and a two-tranche placement to fund full acquisition and development of its Mahalo Gas Project.

HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.

AusQuest has confirmed a continuous 1.5km copper-gold mineralised corridor at its Cangallo project in Peru, with broad intercepts and emerging high-grade zones. Diamond drilling has begun, revealing significant vertical extent and setting the stage for deeper exploration.

Godolphin Resources' JV partner Great Plains Metals has delivered a substantial copper-gold porphyry intercept at Goodrich, NSW, validating the exploration model and highlighting the project's scale potential.

OncoSil Medical reported a 53% increase in unit sales and advanced key regulatory approvals, including FDA final review and TGA listing, positioning it for growth in pancreatic cancer treatment.

BCAL Diagnostics has strengthened its leadership, advanced breast cancer detection tests, and secured key funding and strategic investments to underpin its FY2027 growth plans.

True North Copper (ASX:TNC) reported strong progress in Q4 FY2026, expanding its Mt Oxide copper system and consolidating its Cloncurry assets ahead of a key Pre-Feasibility Study.

Patagonia Lithium (ASX:PL3) reported solid progress in its June quarter, hitting key milestones in drilling, pump testing, and resource modelling at its Argentine lithium brine projects, supported by a strong cash position following recent capital raises.

Fortuna Metals has declared a maiden mineral resource at its Mkanda project in Malawi, ranking it among the top six rutile deposits worldwide, while locking in a strategic US investment of A$8.6 million from WNDR to boost market exposure.

The Calmer Co. has signed a binding heads of agreement with Kaiming Agro Processing to establish a long-term manufacturing partnership, leveraging advanced extraction technology in Fiji to scale its premium botanical ingredients business globally.

Beforepay Group capped FY26 with a robust quarter, delivering record net transaction margins and a significant new credit facility that cuts funding costs.

Resolute Mining reported Q2 2026 gold production of 45,192 ounces with steady operations, while Doropo construction progresses on schedule and the ABC Project's inferred resource grows to 3 million ounces.

Predictive Discovery reported a 33% increase in gold production to 64,026 ounces in Q2 2026, driven by Kiniero’s operational ramp-up and advancing development at the Bankan project.

Rhythm Biosciences bolstered its financial position with a $5.2 million option underwriting while accelerating commercial adoption of its ColoSTAT® colorectal cancer test and advancing geneType™ partnerships internationally in Q4 FY26.

Epiminder has leveraged its $125 million IPO to advance clinical enrolments, boost Medicare reimbursement, and develop its next-generation Minder device, positioning for a commercial launch in early 2028.

Audeara Ltd posted record FY26 cash receipts of $4.2 million and unaudited revenue of $4.44 million, driven by progress in AI audio licensing, exclusive assistive listening deals, and a large-scale Auracast deployment across retirement villages.

Legacy Minerals has significantly expanded its Mt Carrington Mineral Resource Estimate to 47.9 million tonnes containing 1.6 million ounces gold-equivalent, boosting the Indicated category by 69% and setting the stage for an optimised scoping study.

Minerals 260’s Pre-Feasibility Study cements Bullabulling’s status as a high-margin, long-life gold mine with a 38% resource upgrade to 6.2Moz and early construction underway.

Aurora Labs marked its commercial debut by delivering AU4 micro gas turbine propulsion systems to Sovereign Propulsion Systems, while securing a $1 million government grant to scale production and formalising a strategic defence partnership with MBDA.

Pantoro Gold delivered 18,028 ounces in Q4 FY2026 amid operational challenges and sets a FY2027 production target of 90,000 to 105,000 ounces at a lower AISC of A$2,800 to A$3,400 per ounce.

Xpedra Resources has reported its strongest drilling results at the Springfield Gold Deposit, revealing thick, high-grade gold zones over 400 metres of strike and open at depth, alongside shareholder approval for acquiring the high-grade Neeld Gold Project.